PHAXIAM Therapeutics SA (LTS:0QSS)
€ 1.65 0 (0%) Market Cap: 16.39 Mil Enterprise Value: -5.41 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 38/100

Q1 2021 Erytech Pharma SA Earnings Call Transcript

May 05, 2021 / 12:30PM GMT
Release Date Price: €50.92
Operator

Good day, and thank you for standing by. Welcome to the ERYTECH Business Update and Financial Highlights for the First Quarter of 2021. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Mr. Gil Beyen, Chief Executive Officer. You may go ahead, sir.

Gil Beyen
ERYTECH Pharma S.A. - CEO & Director

Thank you, Dexter. Good afternoon. Good morning. (foreign language). Thank you for joining us for our first quarter 2021 earnings call. I hope everyone is well and safe wherever you may be.

We announced our business and financial update yesterday evening. The press release and the Q1 earnings presentation can be found on the Investor Relations page of our website.

And joining me on this call today from 3 different locations are Dr. Iman El-Hariry, our Chief Medical Officer; and Eric Soyer, our Chief Financial and Chief Operating Officer. We are on 3 different locations, and there's some technical issues, but I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot